Literature DB >> 12064656

Hair analysis of seven bodybuilders for anabolic steroids, ephedrine, and clenbuterol.

V Dumestre-Toulet1, V Cirimele, B Ludes, S Gromb, P Kintz.   

Abstract

Several bodybuilders, all winners of international competitions, were arrested for trafficking of a number of doping agents including anabolic steroids, ephedrine, beta-adrenergics, human chorionic gonadotropin, antidepressants, and diuretics. In accordance with the recent French law against doping, the judge asked to test seven bodybuilders to identify doping practices. Hair and urine specimens were collected for analysis. After decontamination, a 100 mg hair strand was pulverized in a ball mill, hydrolyzed, extracted, and derivatized to be tested by GC/MS for anabolic steroids, beta-adrenergic compounds, ephedrine, and other doping agents. Urine was analyzed for anabolic steroids and metabolites, beta-adrenergic compounds, ephedrine, and human chorionic gonadotropin, in addition to a broad spectrum screening with GC/MS. The following compounds were detected in urine: ephedrine (29 and 36 ng/mL, n = 2), clenbuterol (0.2 to 0.3 ng/mL, n = 3), norandrosterone (4.7 to 100.7 ng/mL, n = 7), norethiocholanolone (0.9 to 161.8 ng/mL, n = 6), stanozolol (1 to 25.8 ng/mL, n = 4), methenolone (2.5 to 29.7 ng/mL, n = 4), testosterone (3 to 59.6 ng/mL, n = 7), epitestosterone (1 to 20.4 ng/mL, n = 7) and ratio testosterone/epitestosterone >6 for four subjects (18.5 to 59.6). The following drugs were detected in hair: ephedrine (0.67 and 10.70 ng/mg, n = 2), salbutamol (15 to 31 pg/mg, n = 3), clenbuterol (15 to 122 pg/mg, n = 6), nandrolone (1 to 7.5 pg/mg, n = 3), stanozolol (2 to 84 pg/mg, n = 4), methenolone (17 and 34 ng/ml, n = 2), testosterone enanthate (0.6 to 18.8 ng/mg, n = 5), and testosterone cypionate (3.3 to 4.8 ng/mg, n = 2). These results document the doping practice and demonstrate repetitive exposure to anabolic compounds and confirm the value of hair analysis as a complement to urinalysis in the control of doping practice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12064656

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  5 in total

1.  Detection and quantification of 12 anabolic steroids and analogs in human whole blood and 20 in hair using LC-HRMS/MS: application to real cases.

Authors:  Nicolas Fabresse; Stanislas Grassin-Delyle; Isabelle Etting; Jean-Claude Alvarez
Journal:  Int J Legal Med       Date:  2017-02-24       Impact factor: 2.686

2.  Virtue or pretense? Looking behind self-declared innocence in doping.

Authors:  Andrea Petróczi; Eugene V Aidman; Iltaf Hussain; Nawed Deshmukh; Tamás Nepusz; Martina Uvacsek; Miklós Tóth; James Barker; Declan P Naughton
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

Review 3.  Anabolic Androgenic Steroid (AAS) related deaths: autoptic, histopathological and toxicological findings.

Authors:  Paola Frati; Francesco P Busardò; Luigi Cipolloni; Enrico De Dominicis; Vittorio Fineschi
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

4.  Sudden cardiac death in anabolic androgenic steroids abuse: case report and literature review.

Authors:  Ana Isabel Hernández-Guerra; Javier Tapia; Luis Manuel Menéndez-Quintanal; Joaquín S Lucena
Journal:  Forensic Sci Res       Date:  2019-08-19

5.  Comfort in big numbers: Does over-estimation of doping prevalence in others indicate self-involvement?

Authors:  Andrea Petróczi; Jason Mazanov; Tamás Nepusz; Susan H Backhouse; Declan P Naughton
Journal:  J Occup Med Toxicol       Date:  2008-09-05       Impact factor: 2.646

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.